Copyright
©The Author(s) 2016.
World J Gastrointest Oncol. Apr 15, 2016; 8(4): 389-401
Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.389
Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.389
Figure 1 Illustration of principal pathways involved in cellular differentiation, proliferation, survival and apoptosis: Somatostatin receptors, mammalian target of rapamycin protein kinase B, phosphoinositide 3-kinase and phosphatase and tensin homolog, insulin-like growth factor 1 receptor, vascular endothelial growth factor receptor, epidermal growth factor receptor, transforming growth factor receptor, fibroblast growth factors.
SSTRs: Somatostatin receptors; mTOR: Mammalian target of rapamycin; Akt: Protein kinase B; PI3K: Phosphoinositide 3-kinase; PTEN: Phosphatase and tensin homolog; IGFR: Insulin-like growth factor receptor; VEGFR: Vascular endothelial growth factor receptor; EGFR: Epidermal growth factor receptor; TGFR: Transforming growth factor receptor.
- Citation: Berardi R, Morgese F, Torniai M, Savini A, Partelli S, Rinaldi S, Caramanti M, Ferrini C, Falconi M, Cascinu S. Medical treatment for gastro-entero-pancreatic neuroendocrine tumours. World J Gastrointest Oncol 2016; 8(4): 389-401
- URL: https://www.wjgnet.com/1948-5204/full/v8/i4/389.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i4.389